About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Effects of Cholinergic Augmentation on Measures of Balance and Gait

NCT02206620·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Oregon Health and Science University

With

Michael J. Fox Foundation for Parkinson's Research

Age

30–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

30 years old or older
Diagnosis of idiopathic Parkinson's disease
Stand unassisted (without use of an assistance device) and walk continuously for at least 2 minutes.

You may not be if

musculoskeletal disorders that affect standing and walking
Uncorrected vision disturbance
Vestibular problems
Major depression
Hallucinations or other psychiatric disturbances
Tachycardia
Bradycardia
Arrhythmias
Peptic ulcer disease
Use of anticholinergics
Use of cholinesterase inhibitors
Use of bladder antispasmodics
Use of tricyclic antidepressants

The record

StatusCompleted

PhasePhase 2

Taking part49

StartedJul 2014

UpdatedNov 14, 2019

Conditions

Parkinson's Disease

Where1

Oregon Health & Science University
Portland, Oregon, United States

Clareo Health | Effects of Cholinergic Augmentation on Measures of Balance and Gait